Press release
Uterine Cancer Drugs Market Is Growing with the Increasing Prevalence of Endometrial Cancer
Thus, with the increasing prevalence, the demand for uterine cancer drugs is also increasing. For example, in April 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer with deficient mismatch repair (dMMR), which are genetic anomalies abnormalities that disrupt DNA repair. Both the European Commission (EC) and FDA have granted approval to GlaxoSmithKline’s Jemperli (dostarlimab) for treating endometrial cancer. Moreover, in September 2019, FDA approved a combination of two drugs, Keytruda (pembrolizumab) and Lenvima (lenvatinib), to treat a subset of patients with advanced endometrial carcinoma.
Coherent Market Insights celebrating 5th anniversary and offering 2000 USD off on all reports. Let’s celebrate with us.
Buy Now and Get Instant Discount: https://www.coherentmarketinsights.com/promo/buynow/1745
Elekta AB, Ability Pharma, Apotex Inc, Merck & Co. Inc, Novo Nordisk A/S, Bristol-Myers Squibb Company, CELGENE CORPORATION, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, ALLERGAN, Pfizer Inc, AstraZeneca, Eli Lilly and Company, Novartis AG, Hetero, Alnylam Pharmaceuticals, Inc, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, Biogen, AbbVie Inc, Gilead Sciences.
Segmentation: Global Uterine Cancer Drug Market
By Types
Endometrial Adenocarcinoma
Adenosquamous Carcinoma
Papillary Serous Carcinoma
Uterine Sarcoma
By Mechanism of Action
Angiogenesis Inhibitor
Mammalian Target of Rapamycin (mTOR) Inhibitor
Monoclonal Antibody
Others
By Drugs
Bevacizumab
Everolimus
Temsirolimus
Pembrolizumab
Carboplatin
Others
By Therapy
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Hormone Therapy
Progestin
Tamoxifen
Aromatase inhibitor
By Treatment
Medication
Surgery
Salpingo-Oophorectomy
Lymphadenectomy
Hysterectomy
By Route of Administration
Oral
Intravenous
Others
By Distribution Channel
Direct
Online Pharmacy
Retailers
Others
This in turn is expected to augment the growth of the uterine cancer drugs market in Europe and North America. Chemotherapy is the most recommended therapy for the uterine sarcoma treatment. Various chemotherapy drugs, such as Epirubicin (Ellence), Liposomal doxorubicin (Doxil), Dacarbazine (DTIC), Docetaxel (Taxotere), and Paclitaxel (Taxol), among others, are used for the treatment of uterine sarcoma. However, chemotherapy may not work in certain types of uterine sarcoma. Thus, there is an increasing demand for safe and effective uterine cancer drugs in the market, driving the uterine cancer drugs market growth.
Moreover, the uterine cancer drugs market is expected to witness robust growth, owing to the increasing incidence rate of endometrial cancer worldwide. According to the World Cancer Research Fund International, endometrial cancer is the sixth most commonly occurring cancer in women and the 15th most commonly occurring cancer worldwide. There were over 380,000 new cases in 2018. Women with breast cancer, diabetes, or high blood pressure are at a greater risk of being affected by endometrial cancer. However, the major factors, such as high cost associated with the treatment high toxicity of drugs, and adverse effects of the treatment, are expected to restrain the growth of the uterine cancer drugs market.
For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/uterine-cancer-drugs-market-1745
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle,
WA 98154, U.S.
Phone:
US: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uterine Cancer Drugs Market Is Growing with the Increasing Prevalence of Endometrial Cancer here
News-ID: 2342195 • Views: …
More Releases from Coherent Market Insights
Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent …
The Current Sensor market is estimated to be valued at USD 3.42 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032.
➤ Coherent Market Insights has published an in-depth research report titled "Current Sensor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Current…
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disrupti …
The U.S. Bodyguard Service & Security Consulting market is estimated to be valued at USD 2.57 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate CAGR of 4.6% from 2025 to 2032.
➤ Coherent Market Insights has published an in-depth research report titled "U.S. Bodyguard Service & Security Consulting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This…
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B …
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample…
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample…
More Releases for Uterine
Uterine Fibroids Symptoms
USA Fibroids Center is here to offer detailed information on https://www.usafibroidcenters.com/blog/uterine-fibroids-symptoms/ and help you discuss the best treatments for uterine fibroids at the clinic.
Find out the best Fibroid Treatment for you!
Treatments for uterine fibroids are accessed in women with problems related to them and show symptoms such as heavy menstrual bleeding, pain or pressure in the pelvis, or infertility and sterility.
…
Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroi …
Bharath Hospital Kottayam is excited introduce the latest advancement in women's healthcare - the Uterine Fibroid Embolization (UFE) treatment. Uterine fibroids are non-cancerous growths that form in the uterus. They are a common condition among women, especially those of reproductive age. These tumors can vary in size, from small growths to large masses that can distort the shape of the uterus. Although many women with uterine fibroids experience no symptoms,…
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players…
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape.
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers…
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort.
According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to…
